FindTrial
Sign In

Home-based exercise program (HEP) and concentric versus eccentric-based stair training program (CSTP versus ESTP) for pain and function in knee osteoarthritis

A two-phase double-blinded randomised controlled trial on structured home-based exercise program (HEP) and concentric versus eccentric-based stair training program (CSTP versus ESTP) for pain and function in knee osteoarthritis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/081575
Enrollment
247
Registered
2025-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Home-Based Exercise Program (HEP) Phase I: Participants in the HEP group will perform structured exercises targeting knee strength and mobility for 8-week. The program includes ligh

Sponsors

Kazi Md Azman Hossain
Lead Sponsor
Jashore University of Science and Technology JUST
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: For Phase I - Individuals will be included in this trial if (1) ages 45 70 for both men and women; (2) the presence of knee OA for at least six months following American College of Rheumatology criteria; (3) able to walk without the use of any aids and able to flex the knee beyond 90 degrees; (4) anterior-posterior bilateral standing radiograph presents Kellgren and Lawrence Grade II/III knee OA; (5) having smartphone for watching video tutorial. For Phase II - Individuals will be included if (1) complete Phase I home-based exercise program (HBEP); (2) pain subsides during walking and staring

Exclusion criteria

Exclusion criteria: For Phase I - Individuals will be excluded if (1) knee surgery has been performed in the previous twelve months; (2) lumbar radiculopathy, vascular claudication, severe anterior-sided knee pain resulting from patella-femoral syndrome or chondromalacia, as well as further neurological, muscular, or joint conditions that could impair the function of the lower limbs; (3) visible malformation of the knee, either varus or valgus; (4) Received hyaluronic acid or corticosteroid injections within three months of study enrollment; (5) pregnancy (6) BMI over 30. For Phase II - Individuals will be excluded if (1) present signs of knee OA following American College of Rheumatology criteria;16 (2) the presence of unusual cardiac response during the six-minute walk test and staring.

Design outcomes

Primary

MeasureTime frame
pain (NPRS), pressure pain threshold (Algometer), and functional ability (WOMAC)Timepoint: At baseline, week-8, week-16 and week-24 follow-up—

Secondary

MeasureTime frame
muscle strength (sphygmomanometer), range of motion(goniometer), aerobic capacity (6MWT), and quality of life(SF-36Timepoint: At baseline, week-8, week-16 and week-24 follow-up—

Countries

Bangladesh

Contacts

Public ContactAbid Hasan Khan

Jashore University of Science and Technology (JUST), Jashore

azmanhossain51@gmail.com01660140833

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026